ABL Bio Inc Working Capital to Net Assets Ratio
ABL Bio Inc working capital to net assets ratio. ABL Bio Inc (298380) has a Working Capital to Net Assets ratio of 40.7% as of June 2026. Working capital of ₩70.85 Billion (current assets of ₩169.87 Billion minus current liabilities of ₩99.02 Billion) is measured against net assets of ₩173.94 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of ABL Bio Inc (2016–2025)
Working capital to net assets ratio of ABL Bio Inc from 2016 to 2025. This chart shows how ABL Bio Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 40.7%, reflecting working capital of ₩70.85 Billion against net assets of ₩173.94 Billion KRW. Explore ABL Bio Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
ABL Bio Inc Working Capital to Net Assets Ratio by Year (2016–2025)
ABL Bio Inc working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for ABL Bio Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 298380 asset base.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 33.5% | ₩52.55 Billion | ₩156.70 Billion | ₩176.05 Billion | ₩123.50 Billion | ▼ -14.8 pp |
| 2024 | 48.3% | ₩80.79 Billion | ₩167.28 Billion | ₩144.15 Billion | ₩63.36 Billion | ▲ +2.7 pp |
| 2023 | 45.6% | ₩33.78 Billion | ₩74.08 Billion | ₩75.54 Billion | ₩41.76 Billion | ▲ +33.6 pp |
| 2022 | 12.0% | ₩8.36 Billion | ₩69.51 Billion | ₩80.53 Billion | ₩72.17 Billion | ▼ -53.6 pp |
| 2021 | 65.6% | ₩36.72 Billion | ₩55.95 Billion | ₩45.47 Billion | ₩8.75 Billion | ▼ -4.9 pp |
| 2020 | 70.5% | ₩63.95 Billion | ₩90.66 Billion | ₩71.92 Billion | ₩7.97 Billion | ▼ -24.4 pp |
| 2019 | 94.9% | ₩125.33 Billion | ₩132.01 Billion | ₩134.66 Billion | ₩9.33 Billion | ▼ -0.3 pp |
| 2018 | 95.2% | ₩149.50 Billion | ₩156.96 Billion | ₩161.09 Billion | ₩11.59 Billion | ▲ +104.7 pp |
| 2017 | -9.4% | ₩8.09 Billion | ₩-85.96 Billion | ₩9.44 Billion | ₩1.34 Billion | ▲ +35.1 pp |
| 2016 | -44.6% | ₩5.39 Billion | ₩-12.10 Billion | ₩5.69 Billion | ₩303.04 Million | — |